chr9-2029075-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2

The NM_003070.5(SMARCA2):​c.53G>A​(p.Gly18Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

SMARCA2
NM_003070.5 missense

Scores

6
10
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.72
Variant links:
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SMARCA2. . Gene score misZ: 5.054 (greater than the threshold 3.09). Trascript score misZ: 4.663 (greater than threshold 3.09). The gene has 93 curated pathogenic missense variants (we use a threshold of 10). The gene has 88 curated benign missense variants. GenCC has associacion of the gene with intellectual disability-sparse hair-brachydactyly syndrome, Coffin-Siris syndrome 1.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SMARCA2NM_003070.5 linkc.53G>A p.Gly18Glu missense_variant 2/34 ENST00000349721.8 NP_003061.3 P51531-1Q8N9Q1Q56A76
SMARCA2NM_001289396.2 linkc.53G>A p.Gly18Glu missense_variant 2/34 NP_001276325.1 P51531-1Q8N9Q1B4DSC8
SMARCA2NM_139045.4 linkc.53G>A p.Gly18Glu missense_variant 2/33 NP_620614.2 P51531-2Q8N9Q1Q56A76
SMARCA2NM_001289397.2 linkc.53G>A p.Gly18Glu missense_variant 2/33 NP_001276326.1 P51531F6VDE0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SMARCA2ENST00000349721.8 linkc.53G>A p.Gly18Glu missense_variant 2/345 NM_003070.5 ENSP00000265773.5 P51531-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 20, 2023This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 18 of the SMARCA2 protein (p.Gly18Glu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA2-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SMARCA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.80
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.16
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
.;.;T;D;T;T;T;.;T;T;D
Eigen
Pathogenic
0.68
Eigen_PC
Pathogenic
0.71
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.97
.;D;.;.;.;D;D;D;D;D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Uncertain
0.71
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.67
D
MutationAssessor
Benign
1.8
L;.;.;L;.;.;.;L;.;.;L
PrimateAI
Pathogenic
0.92
D
PROVEAN
Uncertain
-2.5
N;D;.;N;.;.;D;N;D;.;N
REVEL
Uncertain
0.61
Sift
Uncertain
0.0040
D;D;.;D;.;.;D;D;D;.;D
Sift4G
Uncertain
0.0090
D;D;.;D;.;.;D;D;D;.;D
Polyphen
0.98
D;.;.;D;.;.;.;D;.;.;D
Vest4
0.66
MutPred
0.19
Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);Gain of solvent accessibility (P = 0.0062);
MVP
0.77
MPC
0.057
ClinPred
0.94
D
GERP RS
5.5
Varity_R
0.40
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-2029075; API